Cargando…

The Burden of JAK2V617F Mutated Allele in Turkish Patients With Myeloproliferative Neoplasms

BACKGROUND: Studies regarding the impact of JAK2V617F allele burden on phenotypic properties and clinical course in Philadelphia-negative myeloproliferative neoplasms (Ph-negative MPNs) have reported variable results. We aimed to analyze the association of mutated JAK2V617F allele burden with labora...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yonal-Hindilerden, Ipek, Daglar-Aday, Aynur, Akadam-Teker, Basak, Yilmaz, Ceylan, Nalcaci, Meliha, Yavuz, Akif Selim, Sargin, Deniz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4285062/ https://www.ncbi.nlm.nih.gov/pubmed/25584101 http://dx.doi.org/10.14740/jocmr2047w

Ejemplares similares

Prognostic significance of ASXL1, JAK2V617F mutations and JAK2V617F allele burden in Philadelphia-negative myeloproliferative neoplasms
por: Yonal-Hindilerden, Ipek, et al.
Publicado: (2015)

Impact of JAK2V617F Mutational Status on Phenotypic Features in Essential Thrombocythemia and Primary Myelofibrosis
por: Yönal, İpek, et al.
Publicado: (2016)

The Clinical Significance of IDH Mutations in Essential Thrombocythemia and Primary Myelofibrosis
por: Yonal-Hindilerden, Ipek, et al.
Publicado: (2016)

Effects of Mutational Combinations on Philadelphia-Negative Myeloproliferative Neoplasms
por: Ipek, Yonal-Hindilerden, et al.
Publicado: (2017)

Clinical Impact of JAK2V617F Allele Burden in Philadelphia-Negative Myeloproliferative Neoplasms
por: Yönal-Hindilerden, İpek, et al.
Publicado: (2023)

Comprehensive mastocytosis data analysis from a single center
por: Tiryaki, Tarık Onur, et al.
Publicado: (2023)

Hairy cell leukemia followed by polycythemia vera: report of the first case
por: Ipek, Yonal-Hindilerden, et al.
Publicado: (2016)

MALT lymphoma of the left biceps muscle: a rare case with an interesting presentation
por: Yonal-Hindilerden, Ipek, et al.
Publicado: (2016)

Primary Mediastinal Large B-Cell Lymphoma As an Incidental Finding: Report of a Case
por: Yönal-Hindilerden, İpek, et al.
Publicado: (2018)

Budd-Chiari Syndrome: An Unusual Complication of AL Amyloidosis
por: Tiryaki, Tarık Onur, et al.
Publicado: (2020)

Rituximab Therapy in Adults with Refractory Symptomatic Immune Thrombocytopenia: Long-Term Follow-Up of 15 Cases
por: Hindilerden, Fehmi, et al.
Publicado: (2017)

Comparison of Response to Rituximab Therapy in Adults with Refractory Symptomatic Immune Thrombocytopenia According to the Presence of Accessory Spleen
por: Hindilerden, Fehmi, et al.
Publicado: (2022)

Aleukemic Leukemia Cutis Manifesting with Disseminated Nodular Eruptions and a Plaque Preceding Acute Monocytic Leukemia: A Case Report
por: Yonal, Ipek, et al.
Publicado: (2011)

Hairy Cell Leukemia Presenting with Isolated Skeletal Involvement Successfully Treated by Radiation Therapy and Cladribine: A Case Report and Review of the Literature
por: Yonal-Hindilerden, Ipek, et al.
Publicado: (2015)

Primary B-Cell Mucosa-Associated Lymphoid Tissue Lymphoma of the Hard Palate and Parotid Gland: Report of One Case and Review of the Literature
por: Yonal-Hindilerden, Ipek, et al.
Publicado: (2016)

A Case with Hepatic Involvement Mimicking Metastatic Disease in Multiple Myeloma
por: Erciyestepe, Mert, et al.
Publicado: (2020)

A misleading presentation of T cell/histiocyte rich B-cell lymphoma mimicking osteomyelitis
por: Özpolat, Tahsin, et al.
Publicado: (2018)

Allogeneic Hematopoietic Stem Cell Transplantation for Adult Acute Lymphoblastic Leukemia: Results from a Single Center, 1993-2011
por: Yonal-Hindilerden, Ipek, et al.
Publicado: (2017)

Plasmacytoma of the Nasolacrimal Duct Simulating Dacryocystitis: An Uncommon Presentation for Extramedullary Relapse of Multiple Myeloma
por: Kalayoglu-Besisik, Sevgi, et al.
Publicado: (2012)

Case Report: Severe COVID-19 Pneumonia in a Patient With Relapsed/Refractory Hodgkin’s Lymphoma
por: Yonal-Hindilerden, Ipek, et al.
Publicado: (2021)

JAK2 and Beyond: JAK2V617 Mutational Study of Myeloproliferative Disorders and Haematological Malignancies
por: Syeed, Nidda
Publicado: (2019)

JAK2 V617F: A Single Mutation in the Myeloproliferative Group of Disorders
por: McLornan, Donal, et al.
Publicado: (2006)

Gender and Vascular Complications in the JAK2 V617F-Positive Myeloproliferative Neoplasms
por: Stein, Brady L., et al.
Publicado: (2011)

Jak2V617F myeloproliferative neoplasm stem cells and interferon-alpha
por: Lane, Steven W., et al.
Publicado: (2013)

Detection of JAK2 V617F mutation increases the diagnosis of myeloproliferative neoplasms
por: ZHANG, SHU-PENG, et al.
Publicado: (2015)

Rapid progression after ibrutinib discontinuation in a patient with mantle cell lymphoma who has severe coronavirus disease 2019 infection
por: Hindilerden, Fehmi, et al.
Publicado: (2021)

JAK2 mutants (e.g., JAK2V617F) and their importance as drug targets in myeloproliferative neoplasms
por: Gäbler, Karoline, et al.
Publicado: (2013)

JAK out of the box: myeloproliferative neoplasms--associated JAK2 V617F mutations contribute to aortic aneurysms
por: Elf, Shannon E.
Publicado: (2021)

Anti-Glucosylsphingosine Autoimmunity, JAK2V617F-Dependent Interleukin-1β and JAK2V617F-Independent Cytokines in Myeloproliferative Neoplasms
por: Allain-Maillet, Sophie, et al.
Publicado: (2020)

JAK2V617F mRNA metabolism in myeloproliferative neoplasm cell lines
por: Nauroy, P, et al.
Publicado: (2014)

Cardiac hypertrophy associated with myeloproliferative neoplasms in JAK2V617F transgenic mice
por: Shi, Kaiyao, et al.
Publicado: (2014)

Reversine exhibits antineoplastic activity in JAK2(V617F)-positive myeloproliferative neoplasms
por: Lima, Keli, et al.
Publicado: (2019)

Hematopoietic fitness of JAK2(V617F) myeloproliferative neoplasms is linked to clinical outcome
por: Abu-Zeinah, Ghaith, et al.
Publicado: (2022)

A case of chronic lymphocytic leukemia with massive ascites
por: Yonal, Ipek, et al.
Publicado: (2012)

Immune Thrombocytopenia in a Very Elderly Patient With Covid-19
por: Hindilerden, Fehmi, et al.
Publicado: (2020)

Covid-19 associated autoimmune thrombotic thrombocytopenic purpura: Report of a case
por: Hindilerden, Fehmi, et al.
Publicado: (2020)

Absence of JAK2V617F Mutated Endothelial Colony-Forming Cells in Patients With JAK2V617F Myeloproliferative Neoplasms and Splanchnic Vein Thrombosis
por: Guy, Alexandre, et al.
Publicado: (2020)

The telomerase inhibitor imetelstat differentially targets JAK2V617F versus CALR mutant myeloproliferative neoplasm cells and inhibits JAK-STAT signaling
por: Olschok, Kathrin, et al.
Publicado: (2023)

Metformin exerts multitarget antileukemia activity in JAK2(V617F)-positive myeloproliferative neoplasms
por: Machado-Neto, João Agostinho, et al.
Publicado: (2018)

The JAK2V617F-bearing vascular niche promotes clonal expansion in myeloproliferative neoplasms
por: Zhan, H, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_d39f22j6cr5rli0vbpa2a42j83